Needs Assessment

Inflammatory Bowel Disease Monitor systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of IBD. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on their day-to-day practice and is designed to provide management options for clinicians to allow them to better diagnose and treat patients with IBD.

Each issue of Inflammatory Bowel Disease Monitor presents carefully constructed review articles, written by practicing specialists in gastroenterology and related disciplines and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial Advisory Board, and readers.

CME

INTENDED AUDIENCE
Each activity is designed to meet the educational needs of multidisciplinary clinicians and healthcare professionals involved in the care of patients with IBD.

ACCREDITATION
Each activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education and Publishing. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

INSTRUCTIONS FOR OBTAINING CME CREDIT
Participants should download instructions on obtaining credit for the relevant issue. Participants should complete the activity, and fax or mail their responses to the University of Kentucky.

Alternatively, participants should:

1. Go to www.cecentral.com/getcredit
2. Enter the program code for the relevant issue of Inflammatory Bowel Disease Monitor listed below.
3. Follow the online instructions to obtain credit. Participants will receive a confidential report of their results along with the correct answers to each question.

Currently, no CME activities are available.

Paper of the Month

Selected by the Editorial Board this paper has been chosen as THE paper you should read this month:

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn’s disease: a meta-analysis

Click here to read a critique of this paper.